Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Association Between Index of Nutritional Quality and Nonalcoholic Fatty Liver Disease: The Role of Vitamin D and B Group.

Vahid F, Hekmatdoost A, Mirmajidi S, Doaei S, Rahmani D, Faghfoori Z.

Am J Med Sci. 2019 Jul 1. pii: S0002-9629(19)30258-7. doi: 10.1016/j.amjms.2019.06.008. [Epub ahead of print]

PMID:
31326093
2.

Diet-dependent acid load - the missing link between an animal protein-rich diet and non-alcoholic fatty liver disease?

Alferink LJM, Kiefte-de Jong JC, Erler NS, de Knegt RJ, Hoorn EJ, Ikram MA, Janssen HLA, Metselaar HJ, Franco OH, Murad SD.

J Clin Endocrinol Metab. 2019 Apr 12. pii: jc.2018-02792. doi: 10.1210/jc.2018-02792. [Epub ahead of print]

PMID:
30977830
3.

Intakes of magnesium, calcium and risk of fatty liver disease and prediabetes.

Li W, Zhu X, Song Y, Fan L, Wu L, Kabagambe EK, Hou L, Shrubsole MJ, Liu J, Dai Q.

Public Health Nutr. 2018 Aug;21(11):2088-2095. doi: 10.1017/S1368980018000642. Epub 2018 Apr 2.

4.

Nutritional Status and Nutrition Quality in Patients with Non-Alcoholic Fatty Liver Disease.

Vranešić Bender D, Nutrizio M, Jošić M, Ljubas Kelečić D, Karas I, Premužić M, Domislović V, Rotim C, Krznarić Ž.

Acta Clin Croat. 2017 Dec;56(4):625-634. doi: 10.20471/acc.2017.56.04.07.

PMID:
29590715
5.

Serum magnesium concentration is independently associated with non-alcoholic fatty liver and non-alcoholic steatohepatitis.

Eshraghian A, Nikeghbalian S, Geramizadeh B, Malek-Hosseini SA.

United European Gastroenterol J. 2018 Feb;6(1):97-103. doi: 10.1177/2050640617707863. Epub 2017 Apr 25.

6.

Nutrition, inflammation and liver-spleen axis.

Barrea L, Di Somma C, Muscogiuri G, Tarantino G, Tenore GC, Orio F, Colao A, Savastano S.

Crit Rev Food Sci Nutr. 2018;58(18):3141-3158. doi: 10.1080/10408398.2017.1353479. Epub 2017 Nov 30. Review.

PMID:
28799803
7.

[The prospects for the application of the natural and preformed therapeutic factors in the treatment of non-alcoholic fatty liver disease].

Zabolotnaya IB.

Vopr Kurortol Fizioter Lech Fiz Kult. 2016;93(4):42-48. doi: 10.17116/kurort2016442-48. Russian.

PMID:
27500678
8.

Protective role of magnesium isoglycyrrhizinate in non-alcoholic fatty liver disease and the associated molecular mechanisms.

Xu Q, Wang J, Chen F, Lin K, Zhu M, Chen L, Zhou X, Li C, Zhu H.

Int J Mol Med. 2016 Jul;38(1):275-82. doi: 10.3892/ijmm.2016.2603. Epub 2016 May 24.

PMID:
27220460
9.

A green algae mixture of Scenedesmus and Schroederiella attenuates obesity-linked metabolic syndrome in rats.

Kumar SA, Magnusson M, Ward LC, Paul NA, Brown L.

Nutrients. 2015 Apr 14;7(4):2771-87. doi: 10.3390/nu7042771.

10.

Seaweed supplements normalise metabolic, cardiovascular and liver responses in high-carbohydrate, high-fat fed rats.

Kumar SA, Magnusson M, Ward LC, Paul NA, Brown L.

Mar Drugs. 2015 Feb 2;13(2):788-805. doi: 10.3390/md13020788.

11.

Effect of oleic acid on the levels of eight metal ions in human hepatoma SMMC-7721 cells.

Wang S, Kuang X, Fang Z, Huang Z, Shi P.

Biol Trace Elem Res. 2014 Jun;159(1-3):445-50. doi: 10.1007/s12011-014-0018-4. Epub 2014 May 28.

PMID:
24867776
12.

The effect of magnesium supplementation and weight loss on liver enzymes in patients with nonalcoholic fatty liver disease.

Karandish M, Tamimi M, Shayesteh AA, Haghighizadeh MH, Jalali MT.

J Res Med Sci. 2013 Jul;18(7):573-9.

13.

[Magnesium and liver].

Matsui T.

Clin Calcium. 2012 Aug;22(8):1181-7. doi: CliCa120811811187. Review. Japanese.

PMID:
22846353
14.

Prevention of free fatty acid-induced hepatic lipotoxicity in HepG2 cells by magnesium isoglycyrrhizinate in vitro.

Cheng Y, Zhang J, Shang J, Zhang L.

Pharmacology. 2009;84(3):183-90. doi: 10.1159/000235873. Epub 2009 Sep 10.

PMID:
19752584
15.

Orlistat-associated adverse effects and drug interactions: a critical review.

Filippatos TD, Derdemezis CS, Gazi IF, Nakou ES, Mikhailidis DP, Elisaf MS.

Drug Saf. 2008;31(1):53-65. Review.

PMID:
18095746

Supplemental Content

Loading ...
Support Center